{"meshTags":["Adenocarcinoma","Aged","Antimetabolites, Antineoplastic","Deoxycytidine","Humans","Male","Pancreatic Neoplasms"],"meshMinor":["Adenocarcinoma","Aged","Antimetabolites, Antineoplastic","Deoxycytidine","Humans","Male","Pancreatic Neoplasms"],"organisms":["9606","9606","9606","9606"],"publicationTypes":["Case Reports","English Abstract","Journal Article"],"abstract":"We report the case of 75-year-old man with advanced pancreatic cancer who was successfully treated with gemcitabine. The patient was admitted to our hospital suffering from anorexia and body weight loss. CT and ERCP showed pancreatic tail cancer with Schnitzler metastasis. We judged that a curative operation was impossible. Gemcitabine was infused over 30 minutes on an outpatient basis (1,000 mg/m2/week x 3/4 weeks). After 4 courses, the tumor was reduced and the tumor markers decreased. Furthermore, the patient can take sufficient meals without any adverse effects. The patient continues to undergoing the therapy with gemcitabine, and his quality of life has been preserved.","title":"[A case of advanced pancreatic cancer treated with gemcitabine hydrochloride].","pubmedId":"12938271"}